Back to Search
Start Over
Heterogeneous nuclear ribonucleoprotein F deficiency in mouse podocyte promotes podocytopathy mediated by methyltransferase-like 14 nuclear translocation resulting in Sirtuin 1 gene inhibition.
- Source :
-
Translational research : the journal of laboratory and clinical medicine [Transl Res] 2024 May; Vol. 267, pp. 1-9. Date of Electronic Publication: 2024 Jan 07. - Publication Year :
- 2024
-
Abstract
- Heterogeneous nuclear ribonucleoprotein F (HnRNP F) is a key regulator for nucleic acid metabolism; however, whether HnRNP F expression is important in maintaining podocyte integrity is unclear. Nephroseq analysis from a registry of human kidney biopsies was performed. Age- and sex-matched podocyte-specific HnRNP F knockout (HnRNP F <superscript>POD</superscript> KO) mice and control (HnRNP F <superscript>fl/fl</superscript> ) were studied. Podocytopathy was induced in male mice (more susceptible) either by adriamycin (ADR)- or low-dose streptozotocin treatment for 2 or 8 weeks. The mouse podocyte cell line (mPODs) was used in vitro. Nephroseq data in three human cohorts were varied greatly. Both sexes of HnRNP F <superscript>POD</superscript> KO mice were fertile and appeared grossly normal. However, male 20-week-old HnRNP F <superscript>POD</superscript> KO than HnRNP F <superscript>fl/fl</superscript> mice had increased urinary albumin/creatinine ratio, and lower expression of podocyte markers. ADR- or diabetic- HnRNP F <superscript>POD</superscript> KO (vs. HnRNP F <superscript>fl/fl</superscript> ) mice had more severe podocytopathy. Moreover, methyltransferase-like 14 (Mettl14) gene expression was increased in podocytes from HnRNP F <superscript>POD</superscript> KO mice, further enhanced in ADR- or diabetic-treated HnRNP F <superscript>POD</superscript> KO mice. Consequently, this elevated Mettl14 expression led to sirtuin1 (Sirt1) inhibition, associated with podocyte loss. In mPODs, knock-down of HnRNP F promoted Mettl14 nuclear translocation, which was associated with podocyte dysmorphology and Sirt1 inhibition-mediated podocyte loss. This process was more severe in ADR- or high glucose- treated mPODs. Conclusion: HnRNP F deficiency in podocytes promotes podocytopathy through activation of Mettl14 expression and its nuclear translocation to inhibit Sirt1 expression, underscoring the protective role of HnRNP F against podocyte injury.<br />Competing Interests: Declaration of competing interest All authors have nothing to disclose.<br /> (Copyright © 2024. Published by Elsevier Inc.)
Details
- Language :
- English
- ISSN :
- 1878-1810
- Volume :
- 267
- Database :
- MEDLINE
- Journal :
- Translational research : the journal of laboratory and clinical medicine
- Publication Type :
- Academic Journal
- Accession number :
- 38195017
- Full Text :
- https://doi.org/10.1016/j.trsl.2024.01.002